Lily Zhang

Partner

San Diego + 1.858.314.1200

Lily Zhang's practice is dedicated to intellectual property, with an emphasis on patent preparation and prosecution and providing clients with strategic insights in portfolio management. Lily is an engineer by training with deep technical knowledge, and her ability to craft creative solutions for helping companies manage their IP assets provides a tremendous value to clients. Her innovative computational biology and bioinformatics practice is focused on helping clients navigate the intersection of biopharma and high tech. She has experience in a broad range of technical areas, including artificial intelligence and machine learning, computational drug discovery and design, digital pathology, wireless technologies, cybersecurity and cryptography, medical devices, network hardware and software, electronic payment systems, battery composition and production, robotics, optics, and 3D printing and laser fabrication.

Lily has experience in prosecuting U.S. and foreign patent applications. She has prosecuted patent applications in industries such as biotech, data storage, accounting and record management, network security, cloud computing, mobile device security, RFID (radio-frequency identification), video processing, social networking, online games, consumer finances, electronic marketplaces, power generation and storage, and food production.

Lily has written and spoken on many intellectual property-related subjects, including copyright law as it relates to artificial intelligence and machine learning inventions, bioinformatics, and AI-related patents.

Experience

  • Synlico develops patent portfolio related to single-cell bioinformatics and AI-based drug discovery computational platformsJones Day is representing Synlico Inc. in establishing a global patent portfolio related to single-cell bioinformatics and causal artificial intelligence (AI) -based drug discovery computational platforms, which utilize deep generative models and causal structure discovery and inference to identify causal links between intracellular activities and cellular responses within a patient's microenvironment, predicting how cell modulation alters cellular behavior in patients.
  • Additional Speaking Engagements

    • September 26, 2024
      China Grand Global Compliance Forum "Laws Related to Artificial Intelligence"
    • August 28, 2024
      Jones Day Peking University Summer Workshop, "How to plan your career path and tips for working in an international law firm."
    • August 14, 2024
      BioVerse Webinar - Where Science Sparks Business, "Artificial Intelligence in Drug Development"
    • July 31, 2024
      "Gender Bias in AI", Asian Pacific American Bar Association of Silicon Valley
    • June 20, 2024
      PatPros Tech Talk: AI in Drug Discovery
    • April 12, 2024
      University of San Diego School of Law PATCON 12 "Stroke of Artificial Genius: Reinventing the Concept of Inventorship in the Age of Artificial Intelligence"
    • April 3, 2024
      Biocom California "Stroke of Artificial Genius: Reinventing the Concept of Inventorship in the Age of Artificial Intelligence"
    • March 8, 2024
      Women in IP Speaker Series "IP, Advocacy, and Dispute Resolution in the Age of Artificial Intelligence"
    • December 1, 2023
      Cleveland State University College of Law IP+ Conference "Cross-Border Trade in IP"
    • November 6, 2023
      Biocom California "Breaking Down Silos: Harnessing AI for Biopharma Advancement"